Magnetic, biocompatible FeCO(3) nanoparticles for T2-weighted magnetic resonance imaging of in vivo lung tumors

BACKGROUND: Late diagnosis of lung cancer is one of the leading causes of higher mortality in lung cancer patients worldwide. Significant research attention has focused on the use of magnetic resonance imaging (MRI) based nano contrast agents to efficiently locate cancer tumors for surgical removal...

Descripción completa

Detalles Bibliográficos
Autores principales: Thangudu, Suresh, Yu, Chun-Chieh, Lee, Chin-Lai, Liao, Min-Chiao, Su, Chia-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952886/
https://www.ncbi.nlm.nih.gov/pubmed/35337331
http://dx.doi.org/10.1186/s12951-022-01355-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952886/
https://www.ncbi.nlm.nih.gov/pubmed/35337331
http://dx.doi.org/10.1186/s12951-022-01355-3

Ejemplares similares